Pressure-Testing Regulator Alignment Before You Commit to Market Entry

Start by writing down what the board actually believes

Before you can test regulator alignment, you have to make the board's assumptions explicit. Most entry decisions rest on three or four unspoken beliefs: that the licensing route is workable, that the host regulator views your business model as familiar, that your home-country supervisor will not object, and that the political mood is neutral or favourable. These beliefs are usually held with more confidence than the evidence supports.

Get the executive sponsor to write each assumption as a testable statement. Not "the regulator is open to fintech entrants" but "the regulator has authorised at least two comparable entrants in the last 24 months, with conditions we can meet." Vague assumptions cannot be falsified, and unfalsifiable beliefs are what sink market entries.

Rank assumptions by cost of being wrong

Not every assumption deserves the same scrutiny. Sort them by two questions: how much capital or reputation is at stake if this is wrong, and how reversible is the decision that depends on it? Assumptions that are high-cost and irreversible, typically around licensing, capital treatment, and conduct expectations, get the deepest testing. Assumptions about, say, distribution partnerships can be tested later.

This is where boards often go wrong. They test the easy things because those produce clean answers, and they defer the hard questions about regulator temperament until the application is already drafted.

Build a regulator position map, not a stakeholder list

A list of names is not intelligence. What you need is a view of each relevant regulator's current position on the specific questions your entry raises. That means:

• The stated policy position, from speeches, consultation responses, and enforcement actions in the last 18 months.
• The revealed position, from how they have actually handled comparable cases, including ones that did not make the news.
• The internal centre of gravity: which division owns the file, who the decision-maker is, and what their track record suggests about risk appetite.

Go beyond the head of authorisations. The technical specialists who write the recommendation memo often matter more than the person who signs it.

Run structured soundings, not casual conversations

The classic mistake is a partner at your law firm having "a quiet word" with a regulator contact and reporting back that things look fine. That tells you almost nothing. Regulators are trained to be non-committal in informal settings, and friendly signals get over-interpreted by people who want the deal to happen.

Good soundings are structured. Prepare a short, specific set of questions grounded in your business model. Use channels that produce a real response: pre-application meetings, industry association roundtables where your issue is on the agenda, formal supervisory dialogue if you already have a relationship. Where you cannot ask directly, use proxies: how did the regulator respond to the last three comparable applications, and what conditions did they attach?

Triangulate. One source is an anecdote. Three consistent sources from different vantage points is a signal.

Test for the positions that would kill the deal

Spend most of your effort trying to disprove the board's thesis, not confirm it. Ask: what would we need to see to conclude the regulator is not aligned? Then go looking for that evidence specifically. If you cannot find it, your confidence is earned. If you find it and explain it away, you are rationalising.

Pay attention to second-order stakeholders: the finance ministry, the central bank, consumer bodies, and the political level above the regulator. A supervisor who is personally comfortable can still be constrained by pressure from above.

Decide what the evidence actually supports

Bring the findings back to the board as a position on each original assumption: confirmed, contradicted, or unresolved. Unresolved is a legitimate answer and often the most important one. It tells the board where the risk sits.

What good looks like: the board approves market entry with a clear view of which assumptions are still open, what would trigger a pause, and who owns each ongoing test. What bad looks like: a green-light decision with regulator alignment treated as a completed workstream rather than a live one.

Your next move

Before the next board meeting, list the three assumptions about regulator alignment that would cost you most if wrong. If you cannot name the specific evidence supporting each one, you do not yet have a validated entry case. That is the conversation to have now, not after the application goes in.